Literature DB >> 17323011

Selective inhibition of the pacemaker channel I(f) improves symptoms in severe dilated cardiomyopathy.

Uta C Hoppe, Karl La Rosée, Robert Larbig, Erland Erdmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17323011     DOI: 10.1007/s00392-007-0500-5

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  5 in total

1.  Long-acting verapamil and heart failure.

Authors:  S K Mohindra; G O Udeani
Journal:  JAMA       Date:  1989-02-17       Impact factor: 56.272

2.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2005-09-13       Impact factor: 29.690

3.  Hyperpolarization-activated inward current in ventricular myocytes from normal and failing human hearts.

Authors:  U C Hoppe; E Jansen; M Südkamp; D J Beuckelmann
Journal:  Circulation       Date:  1998 Jan 6-13       Impact factor: 29.690

4.  A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction.

Authors:  Matthias Manz; Marcus Reuter; Gerhard Lauck; Hegder Omran; Werner Jung
Journal:  Cardiology       Date:  2003       Impact factor: 1.869

5.  Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.

Authors:  Paul Mulder; Stephane Barbier; Abdeslam Chagraoui; Vincent Richard; Jean Paul Henry; Françoise Lallemand; Sylvanie Renet; Guy Lerebours; Florence Mahlberg-Gaudin; Christian Thuillez
Journal:  Circulation       Date:  2004-02-23       Impact factor: 29.690

  5 in total
  5 in total

1.  Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia.

Authors:  R Zhang; A Haverich; M Strüber; A Simon; M Pichlmaier; Christoph Bara
Journal:  Clin Res Cardiol       Date:  2008-07-21       Impact factor: 5.460

2.  Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure.

Authors:  Andreas Link; Jan Christian Reil; Simina Selejan; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2009-06-23       Impact factor: 5.460

3.  Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure.

Authors:  Richard Steinacher; John T Parissis; Bernhard Strohmer; Jörg Eichinger; Dennis Rottlaender; Uta C Hoppe; Johann Altenberger
Journal:  Clin Res Cardiol       Date:  2012-03-07       Impact factor: 5.460

Review 4.  Perspectives of I(f) inhibition by ivabradine in cardiology.

Authors:  Michael Böhm; Jan-Christian Reil
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Usefulness Of Ivabradine To Treat "unexpected" Heart Failure Caused By "acute" Right Ventricular Pacing.

Authors:  Ermenegildo de Ruvo; Francesco Sebastiani; Luigi Sciarra; Alessandro Fagagnini; Leonardo Calo
Journal:  Indian Pacing Electrophysiol J       Date:  2011-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.